U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07382908) titled 'Bioequivalence Study of BGM0504 Injection' on Jan. 26.
Brief Summary: This is a study to evaluate the bioequivalence of a single subcutaneous injection of BGM0504 multi-dose pen (experimental formula T1) and BGM0504 single-dose pen (experimental formula T2) with BGM0504 single-dose pen (reference formula R).
Study Start Date: Dec. 23, 2025
Study Type: INTERVENTIONAL
Condition:
Overweight/Obesity
Intervention:
DRUG: BGM0504 Injection multi-dose pen
5 mg, single subcutaneous injection in the abdominal region
DRUG: BGM0504 Injection single-dose pen
5 mg, single subcutaneous injection in the abdominal region
DRUG: BGM0504 Injec...